We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 276 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

294% more first-time investments, than exits

New positions opened: 276 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8472,031 (+184)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+184
Holders Change %
+9.96%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
276
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
1326
CIM Investment Management
Pennsylvania
$811K -$845K -1,803 -51%
MCCP
1327
Mission Creek Capital Partners
California
$810K
OIA
1328
OneDigital Investment Advisors
Kansas
$801K +$458K +976 +131%
LHC
1329
Little House Capital
Massachusetts
$798K -$14.1K -30 -2%
BS
1330
Boenning & Scattergood
Pennsylvania
$797K +$414K +882 +106%
AAIM
1331
Asset Advisors Investment Management
Georgia
$792K +$46.9K +100 +6%
BP
1332
BBR Partners
New York
$790K +$25.3K +54 +3%
ADL
1333
Asset Dedication LLC
California
$785K +$2.81K +6 +0.4%
IA
1334
Insight Advisors
Pennsylvania
$785K +$790K +1,685 New
CF
1335
Copperwynd Financial
Arizona
$783K -$46K -98 -6%
GSIS
1336
Global Strategic Investment Solutions
Arizona
$783K
WSTAM
1337
Wilbanks Smith & Thomas Asset Management
Virginia
$770K -$23.9K -51 -3%
CW
1338
CreativeOne Wealth
Kansas
$769K +$775K +1,652 New
RM
1339
Resource Management
Louisiana
$766K +$93.3K +199 +14%
MSFS
1340
Main Street Financial Solutions
Pennsylvania
$765K +$770K +1,642 New
QT
1341
Quantamental Technologies
New York
$764K +$769K +1,640 New
NAS
1342
Nicolet Advisory Services
Wisconsin
$755K -$23K -49 -3%
CC
1343
Courier Capital
New York
$750K -$66.6K -142 -8%
LCM
1344
LCM Capital Management
Illinois
$750K +$754K +1,608 New
KOCAA
1345
Knights of Columbus Asset Advisors
Connecticut
$747K -$133K -283 -15%
AIM
1346
Aspen Investment Management
Michigan
$745K
LSV Asset Management
1347
LSV Asset Management
Illinois
$745K
MFG
1348
Menard Financial Group
Texas
$745K +$55.8K +119 +8%
TFO
1349
Tarbox Family Office
California
$741K +$9.38K +20 +1%
AL
1350
Aspiriant LLC
California
$741K +$25.3K +54 +4%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 276 funds opened new TMO positions and 70 closed out — a net gain of 206 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,847 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 276 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +206 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.